Ocular Therapeutix (OCUL) Gross Margin Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9,781.00 |
| Dec 31, 2025 | -33,891.00 |
| Sep 30, 2025 | 9,876.00 |
| Jun 30, 2025 | 37,772.00 |
| Mar 31, 2025 | 14,104.00 |
| Dec 31, 2024 | -67,316.00 |
| Sep 30, 2024 | 74,895.00 |
| Jun 30, 2024 | 110,236.00 |
| Mar 31, 2024 | 67,131.00 |
| Dec 31, 2023 | -22,443.00 |
| Sep 30, 2023 | -3,867.00 |
| Jun 30, 2023 | 6,035.00 |
| Mar 31, 2023 | 20,181.00 |
| Dec 31, 2022 | 17,823.00 |
| Sep 30, 2022 | 53,399.00 |
| Jun 30, 2022 | 155,040.00 |
| Mar 31, 2022 | 120,012.00 |
| Dec 31, 2021 | 124,051.00 |
| Sep 30, 2021 | 1,270.00 |
| Jun 30, 2021 | -4,780.00 |
| Mar 31, 2021 | -8,634.00 |
| Dec 31, 2020 | 116,117.00 |
| Sep 30, 2020 | 11,099.00 |
| Jun 30, 2020 | -16,536.00 |
| Mar 31, 2020 | -24,976.00 |
| Dec 31, 2019 | 104,635.00 |
| Sep 30, 2019 | -79,511.00 |
| Jun 30, 2019 | -109,092.00 |
| Mar 31, 2019 | 46,786.00 |